ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
-
BriaCell Therapeutics Announces Closing of $13.8 million Public Offering
-
BriaCell Therapeutics Announces Closing of Public Offering
-
BriaCell Therapeutics Announces Pricing of Public Offering
-
BriaCell Therapeutics (BCTX) Announces Proposed Public Offering of Common Shares
-
BriaCell Therapeutics Announces Proposed Public Offering of Common Shares
-
BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering
-
BriaCell Therapeutics Announces Proposed Public Offering
-
BriaCell Therapeutics Announces Closing of $5 Million Offering
-
BriaCell Therapeutics (BCTX) Announces $5 Million Offering
-
BriaCell Therapeutics Announces $5 Million Offering
-
BriaCell Therapeutics Announces Closing of $8.5 Million Offering
-
BriaCell Therapeutics (BCTX) Announces $8.5 Million Offering of Common Shares, Warrants
-
BriaCell Therapeutics Announces $8.5 Million Offering
-
BriaCell Therapeutics Corp. Announces Closing of US$27.2 Million Private Placement
-
BriaCell Announces Closing of Over-Allotment Option in Connection with U.S. Public Offering, Bringing Total Gross Proceeds to US$28.7 Million
-
BriaCell Announces Closing of US$25 Million Public Offering
-
BriaCell Announces Pricing of US$25 Million Public Offering and Nasdaq Listing
-
BriaCell Therapeutics Corp. Closes Debt Financing
-
BriaCell Announces Proposed Public Offering in the United States and Listing on NASDAQ

